Turtletree Raises Us$30 Million In First Tranche Of Series A Funding

Nov 01, 2021•almost 4 years ago

Amount Raised

$30 Million

Round Type

series a

San Francisco

Description

TurtleTree has successfully raised US$30 million in the first tranche of their Series A funding, one of the largest investment rounds to date in Asia's cell-based food sector. Rapidly gaining prominence for its novel use of cell-based technology in milk production, the biotech company has now secured fresh funding from investors worldwide, including lead investor VERSO Capital.

Company Information

Company

Turtle Tree

Location

San Francisco, California, United States

About

TurtleTree is a biotech company dedicated to producing a new generation of nutrition—one that's better for the planet, better for the animals, and better for people everywhere. Utilizing its proprietary, cell-based technology, the company is creating better-for-you milk ingredients sustainably and affordably, with benefits that extend beyond the dining table and into the heart of humanity. For more information, please visit TurtleTree's website and follow them on Instagram, Twitter, and LinkedIn.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech